Cinaciguat Hydrochloride and its Impurities

Cinaciguat Hydrochloride (also known as BAY 58-2667) is an investigational drug developed for the treatment of acute decompensated heart failure (ADHF). It belongs to a class of drugs known as soluble guanylate cyclase (sGC) activators. Reference standards of Cinaciguat Hydrochloride API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.